Home NDC 13672-053 Betapace
Product NDC 13672-053
11-digit product format 136720053
Labeler code 13672
Product ID 13672-053_d723021a-3258-876b-e053-2995a90a3e77
Type HUMAN PRESCRIPTION DRUG
Nonproprietary name sotalol HCl
Dosage form TABLET
Route ORAL
Labeler Skyepharma Production SAS
Application NDA019865
Marketing category NDA
Marketing start 1992-10-30
Marketing end 0000-00-00
Substance SOTALOL HYDROCHLORIDE
Active strength 160 mg/160mg
Pharmacologic classes Adrenergic beta-Antagonists [MoA], Antiarrhythmic [EPC], Cardiac Rhythm Alteration [PE]
NDC exclude flag No
Listing certified through 2023-12-31
Current FDA listing Historical FDA.report record Observed NDC auxiliary status history# This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
Historic NDC status page 1 of 1 · 12 matching rows.
View current auxiliary records. · View the auxiliary file history.
Captured / source date, Dataset, Scope table Captured / source date Dataset Scope Package NDC Snapshot Source SHA-256 2025-12-14 17:58 UTC · source 2025-12-05 excluded product product d630ba8d3edf…732f749b63fb…2025-12-14 17:58 UTC · source 2025-12-05 excluded package package 13672-053-00 d630ba8d3edf…732f749b63fb…2025-08-27 00:01 UTC · source 2025-08-26 excluded product product f5e01cc5f278…a2eaf40c39c3…2025-08-27 00:01 UTC · source 2025-08-26 excluded package package 13672-053-00 f5e01cc5f278…a2eaf40c39c3…2025-04-01 02:39 UTC · source 2025-03-31 excluded product product 2ef7874e63bc…57b86245f4fa…2025-04-01 02:39 UTC · source 2025-03-31 excluded package package 13672-053-00 2ef7874e63bc…57b86245f4fa…2025-03-28 20:22 UTC · source 2025-03-28 excluded product product a1b67e2a42f9…c4cf2c586c0d…2025-03-28 20:22 UTC · source 2025-03-28 excluded package package 13672-053-00 a1b67e2a42f9…c4cf2c586c0d…2025-03-22 03:12 UTC · source 2025-03-21 excluded product product cfe11265f3b6…090c488252e2…2025-03-22 03:12 UTC · source 2025-03-21 excluded package package 13672-053-00 cfe11265f3b6…090c488252e2…2025-03-10 12:48 UTC · source 2025-03-10 excluded product product cdf11ea48f46…ba0047e9e063…2025-03-10 12:48 UTC · source 2025-03-10 excluded package package 13672-053-00 cdf11ea48f46…ba0047e9e063…
Source provenance: Browse the complete Orange Book source catalog · source snapshot 1 .
Orange Book products# Current product rows page 1 of 1 · 5 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date N019865-001 BETAPACE SOTALOL HYDROCHLORIDE 80MG TABLET / ORAL AB RLD 1992-10-30 N019865-002 BETAPACE SOTALOL HYDROCHLORIDE 160MG TABLET / ORAL AB RLD, RS 1992-10-30 N019865-003 BETAPACE SOTALOL HYDROCHLORIDE 240MG TABLET / ORAL AB RLD 1992-10-30 N019865-004 BETAPACE SOTALOL HYDROCHLORIDE 320MG TABLET / ORAL 1992-10-30 N019865-005 BETAPACE SOTALOL HYDROCHLORIDE 120MG TABLET / ORAL AB RLD 1994-04-20
Therapeutic equivalence codes# Current TE-code rows page 1 of 1 · 4 matching rows.
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Product history page 1 of 6 · 205 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-02-19 14:30 UTC 2026-02 N019865-001 BETAPACE 80MG TABLET / ORAL AB RLD 1992-10-30 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N019865-002 BETAPACE 160MG TABLET / ORAL AB RLD, RS 1992-10-30 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N019865-003 BETAPACE 240MG TABLET / ORAL AB RLD 1992-10-30 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N019865-004 BETAPACE 320MG TABLET / ORAL 1992-10-30 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N019865-005 BETAPACE 120MG TABLET / ORAL AB RLD 1994-04-20 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N019865-001 BETAPACE 80MG TABLET / ORAL AB RLD 1992-10-30 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N019865-002 BETAPACE 160MG TABLET / ORAL AB RLD, RS 1992-10-30 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N019865-003 BETAPACE 240MG TABLET / ORAL AB RLD 1992-10-30 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N019865-004 BETAPACE 320MG TABLET / ORAL 1992-10-30 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N019865-005 BETAPACE 120MG TABLET / ORAL AB RLD 1994-04-20 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 N019865-001 BETAPACE 80MG TABLET / ORAL AB RLD 1992-10-30 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N019865-002 BETAPACE 160MG TABLET / ORAL AB RLD, RS 1992-10-30 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N019865-003 BETAPACE 240MG TABLET / ORAL AB RLD 1992-10-30 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N019865-004 BETAPACE 320MG TABLET / ORAL 1992-10-30 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N019865-005 BETAPACE 120MG TABLET / ORAL AB RLD 1994-04-20 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N019865-001 BETAPACE 80MG TABLET / ORAL AB RLD 1992-10-30 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N019865-002 BETAPACE 160MG TABLET / ORAL AB RLD, RS 1992-10-30 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N019865-003 BETAPACE 240MG TABLET / ORAL AB RLD 1992-10-30 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N019865-004 BETAPACE 320MG TABLET / ORAL 1992-10-30 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N019865-005 BETAPACE 120MG TABLET / ORAL AB RLD 1994-04-20 fd3edfee7708…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N019865-001 BETAPACE 80MG TABLET / ORAL AB RLD 1992-10-30 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N019865-002 BETAPACE 160MG TABLET / ORAL AB RLD, RS 1992-10-30 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N019865-003 BETAPACE 240MG TABLET / ORAL AB RLD 1992-10-30 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N019865-004 BETAPACE 320MG TABLET / ORAL 1992-10-30 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N019865-005 BETAPACE 120MG TABLET / ORAL AB RLD 1994-04-20 b8a1b40f171c…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N019865-001 BETAPACE 80MG TABLET / ORAL AB RLD 1992-10-30 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N019865-002 BETAPACE 160MG TABLET / ORAL AB RLD, RS 1992-10-30 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N019865-003 BETAPACE 240MG TABLET / ORAL AB RLD 1992-10-30 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N019865-004 BETAPACE 320MG TABLET / ORAL 1992-10-30 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N019865-005 BETAPACE 120MG TABLET / ORAL AB RLD 1994-04-20 03ed91905a0d…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N019865-001 BETAPACE 80MG TABLET / ORAL AB RLD 1992-10-30 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N019865-002 BETAPACE 160MG TABLET / ORAL AB RLD, RS 1992-10-30 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N019865-003 BETAPACE 240MG TABLET / ORAL AB RLD 1992-10-30 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N019865-004 BETAPACE 320MG TABLET / ORAL 1992-10-30 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N019865-005 BETAPACE 120MG TABLET / ORAL AB RLD 1994-04-20 2680178bc6a6…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N019865-001 BETAPACE 80MG TABLET / ORAL AB RLD 1992-10-30 5bbf6a4d5a75…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N019865-002 BETAPACE 160MG TABLET / ORAL AB RLD, RS 1992-10-30 5bbf6a4d5a75…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N019865-003 BETAPACE 240MG TABLET / ORAL AB RLD 1992-10-30 5bbf6a4d5a75…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N019865-004 BETAPACE 320MG TABLET / ORAL 1992-10-30 5bbf6a4d5a75…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N019865-005 BETAPACE 120MG TABLET / ORAL AB RLD 1994-04-20 5bbf6a4d5a75…
Observed Orange Book normalized TE history# Normalized TE history page 1 of 5 · 164 observed states.
openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 1 of 1 · 1 matching rows.
Brand, Generic, Manufacturer table Brand Generic Manufacturer SPL set ID Effective date Available safety fields Join BETAPACE SOTALOL HYDROCHLORIDE Legacy Pharma USA, Inc. a6a7702f-36c9-45db-b640-453dc324baee 2024-12-16 Boxed warning, Warnings, Adverse reactions Exact identifier application applno (NDA): 019865 application number: NDA019865
Packages# Package NDC, 11-digit format, Description table Package NDC 11-digit format Description Units Marketing start Marketing end Sample Exclude flag Status 13672-053-00 13672005300 100 mg in 1 BOTTLE (13672-053-00) 100 mg 1992-10-30 0000-00-00 No No Current